Comprehensive Regulatory Support

Douglas's regulatory team possesses extensive experience navigating diverse global markets. We adeptly understand the nuanced expectations of both international and local regulatory frameworks. New Zealand's drug approval processes align closely with those of other global regions, ensuring a streamlined regulatory landscape.

A key advantage of conducting clinical trials in New Zealand is the expedited initiation of studies compared to other jurisdictions. This accelerated timeline significantly enhances development efficiency.

For our CDMO clients, we prioritize their specific needs. Our development teams collaborate closely to ensure timely generation and presentation of data essential for regulatory submissions in a format that meets stringent requirements.

Review our expertise across a wide range of global markets, with a particular focus on softgels. Our experience in securing regulatory approvals and navigating market challenges positions us as a trusted partner for pharmaceutical companies.